92 Patienter bør nøje monitoreres for at sikre, at den lavest godkendte dosis MIRCERA anvendes til at sørge for tilstrækkelig kontrol af de anæmiske symptomer.
82 Patients should be monitored closely to ensure that the lowest approved dose of MIRCERA is used to provide adequate control of the symptoms of anaemia.